Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of nosocomial and community infections (1) . It is usually present in the environment as well as in the microbiota of the superior respiratory tract and skin. MRSA is transmitted by direct contact, and patient-to-patient transmission is largely via the hands of health care providers (HCPs). Undetected MRSAcolonized HCPs represent a major source of the bacterium in hospitals, since it can be transmitted from these individuals to high-risk patients, which can limit the success of other control measures. Indeed, a case in which MRSA transmission was reduced after carrier HCPs were identifi ed and successfully decolonized has been described (2) .
Individuals with human immunodefi ciency virus/acquired immune defi ciency syndrome (HIV/AIDS) are at increased risk for MRSA colonization and infection mainly due to their high antibiotic use (1) and high rates of hospital readmission. These patients can also harbor community-acquired MRSA, which often produces Panton-Valentine leukocidin (PVL) (1) . However, the prevalence of MRSA colonization in this group is not well established.
We addressed this in the present study by investigating the rate of MRSA colonization in hospitalized AIDS patients and their HCPs. MRSA isolates were characterized genetically and phenotypically and compared to determine whether any transmission occurred between patients and/or HCPs. The isolates were also compared to isolate from 2009 that were collected from different patients at the same hospital.
RESULTS

METHODS
Sample collection
MRSA samples from two colonization sites [nares (N) and saliva (S)] were obtained from HIV/AIDS patients on days 1 and 7 of hospitalization and from HCPs with whom they had contact, in two specifi c units of a large Brazilian public hospital with 600 beds, of which 24 are occupied almost exclusively by HIV patients. From August 2011 to May 2013, 317 individuals with HIV/AIDS were hospitalized, and 266 agreed to participate in the study along with 73 HCPs; staffs that were on leave were not included. Samples were collected using swabs and stored in Stuart agar until bacterial isolation and identifi cation. S. aureus was isolated on Mueller Hinton agar supplemented with 5% sheep blood and phenotypic identifi cation was carried out using the Vitek system (BioMérieux, Marcy l'Etoile, France). Methicillin resistance was detected using the AST-P585 card (BioMérieux) and broth dilution. Once an HCP was identifi ed as being colonized with MRSA, a decolonization protocol was carried out that included a chlorhexidine bath and application of 1ml silver sulfadiazine to the nares, which was repeated daily for 5 days. Additionally, 22 MRSA isolates from other patients from different wards at the same hospital collected between June and September 2009 that were archived by our group, and S. aureus strain N315 were included for determination of clonality. Isolates representing each pulsotype detected by pulsed-fi eld gel electrophoresis (PFGE) were randomly selected for typing by multilocus sequence typing (MLST) and Staphylococcus Cassette Chromosome (SCCmec) typing. The study protocol was approved by the Research Ethics Committee of the Ribeirão Preto School of Nursing (no. 1304/2011).
Susceptibility profi ling
The minimum inhibitory concentration (MIC) was determined for oxacilin, vancomycin, teicoplanin, daptomycin, tigecyclin, linezolid, and quinupristin-dalfopristin by broth dilution, according to Clinical and Laboratory Standards Institute (CLSI) guidelines (3) . MIC 50 and MIC 90 were calculated and CLSI breakpoints were adopted for classification except in the case of tigecycline, for which the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendation was followed (4) .
Heterogeneous vancomycin-intermediate
Staphylococcus aureus screening
Heterogeneous vancomycin-intermediate Staphylococcus aureus screening (hVISA) screening was performed as previously described (5) . If a countable number (one to 30) of colonies was observed within 48h of incubation at 37°C on brain-heart infusion agar containing 4μg/ml vancomycin, the strain was designated as a possible hVISA (5) . S. aureus Mu3 and Mu50 were used as hVISA and VISA control strains, respectively, and were kindly provided by Keiichi Hiramatsu and Teruyo Ito (Juntendo University, Tokyo, Japan).
Population analysis profi le
The population analysis profi le (PAP) (5) (6) to vancomycin or daptomycin was determined for samples that were positive for the hVISA screening or exhibited resistance to daptomycin after 48h of incubation (6) (7) (8) . PAP to daptomycin was used to identify heterogeneous daptomycin-resistant Staphylococcus aureus (hDRSA) strains (8) .
Panton-Valentine leukocidin gene and hemolysis analysis
The PVL gene lukSF was amplifi ed by PCR as previously described (9) . Mueller Hinton agar supplemented with 5% sheep blood was used to assess hemolytic activity.
Molecular characterization
SCCmec type was determined by multiplex-PCR as previously described (10) using the following reference strains: S. aureus RN4220 (SCCmec negative), 10442 (SCCmecI), N315 (SCCmecII), 85/2082 (SCCmecIII), 4744 (SCCmecIVa), and WIS (SCCmecV).
PFGE was carried out after DNA digestion with SmaI (11) . Data were analyzed with Bionumerics v.7.1 software (Applied Maths NV, Belgium) (12) using the unweighted pair-group method with arithmetic mean based on Dice coefficients, where optimization and tolerance were set to 0.5% and 1.25%, respectively. A similarity coeffi cient of 80% was selected to describe patterns representative of each pulsotype, which were further characterized by MSLT (13) . Sequence types were identifi ed using the MLST database (14) . To limit redundancy, duplicate isolates from the same patient with identical SCCmec and pulsotype were considered as the same strain and included only once in the analysis.
Staphylococcus aureus was cultured from 101 (38%) tested individuals, and resistance to oxacillin was observed in 15 participants (5.6% of all participants or 14.8% of those colonized by S. aureus). A total of 13/15 HIV patients were found to be colonized by MRSA on the day of hospital admission, and only fi ve of these remained colonized on day 7. Additionally, two patients were found to be colonized only on day 7 of hospitalization. Only 3/73 (4.1%) of HCPs (P1, P2, and P3) were colonized by MRSA during the study. P1 was colonized on three different dates, despite having undergone decolonization procedures (15) . Therefore, a total of 29 MRSA isolates were characterized: 24 from patients and fi ve from HCPs (Figure 1) .
Susceptibility analysis confi rmed β-lactam resistance in all putative MRSA isolates. Daptomycin resistance in isolate 80N was observed after a 48-h incubation; this was unexpected, since daptomycin is considered bactericidal. A population analysis of the isolate revealed a heterogeneous phenotype that included some daptomycin-resistant cells (Figure 2A) . One isolate (176N) was identified as hVISA, which was confirmed by PAP ( Figure 2B ). According to CLSI breakpoints (3) , this isolate exhibited an intermediate level of resistance to teicoplanin after 24h of incubation (MIC = 16μg/ ml) and full resistance after 48h. However, it would be classifi ed as resistant after 24h based on EUCAST breakpoints (4) .
MIC 50 and MIC 90 (μg/ml) of all antimicrobials were determined for each strain, and were as follows: 128/>256 for oxacilin, 4/4 for linezolid, 0.5/1 for teicoplanin, 0.125/0.5 for tigecycline, 0.5/0.5 for quinupristin/dalfopristin and daptomycin, and 1/2 for vancomycin. MICs for each isolate are shown in Figure 1 . Only 2/29 isolates (6.9%) were PVL-positive (strains 199N and 273N), while 25 (86.2%) were fully hemolytic. Isolates from HIV patients showed considerable variation in terms of PFGE band patterns, which included eight pulsotypes (A-E, G, H, and J) in contrast to three pulsotypes (F, I, and K) among isolates from HCPs.
ST5, ST105, ST148, ST239, and ST30 were detected among isolates. Two of three HCPs were colonized by ST105-SCCmecII, a single locus variant (SLV) of the New York/ Japan Clone, whereas one was colonized by ST5-SCCmecIV, the Pediatric Clone. The following lineages were observed in HIV patients: ST5-SCCmecIV, ST239-SCCmecIII, ST30-SCCmecIV (Southern Pacifi c clone), ST5-SCCmecV, ST105-SCCmecII, and ST148-SCCmecIV, all of which have been previously described (16) (17) . Different SCCmec types were observed in isolates collected from Patient #7 on days 1 and 7 of hospitalization, although they were indistinguishable by PFGE (Figure 1) .
Only Patients #1 and #12 were readmitted to this hospital during the period of study. Isolates from these patients from days 1 and 7 of hospitalization were indistinguishable. Although both isolates from Patient #1 collected at readmission were of the same lineage as that obtained at the fi rst hospitalization (ST239-SCCmecIII), they were of a different pulsotype (G instead of H), and the isolates from days 1 and 7 of readmission were of different subtypes (G3 and G2). Isolates obtained from Patient #12 over a two-month period were indistinguishable and MRSA was detected only on day 1 of both hospitalizations.
The fi rst P1 isolate (PAS 4N) was characterized by PFGE as pulsotype F. After decolonization (15) , this HCP remained colonized by the same MRSA clone (PAS 63N). A second decolonization procedure was carried out, and P1 was again found to be colonized, but this time by pulsotype K strain PAS 65N. Although the pulsotype had changed, all three isolates from P1 were of ST105-SCCmecII. There were no HIV patients colonized by the same type of MRSA as determined by PFGE of HCP samples examined during the course of this study.
When MRSA isolated in 2009 from different infection sites from patients in different wards of the same hospital was compared to those of HIV patients and HCPs in the current study, we observed that with the exception of pulsotype H associated with Brazilian Epidemic Clone (BEC), all other HIV patient isolates were unrelated to those obtained from patients in 2009 (< 80% similarity) (Figure 1) . However, HCPs P1 (isolates PAS 4N and PAS 63N) and P3 (isolate PAS 31N) were colonized in 2011 by clones that were indistinguishable from those isolated from infections at this hospital in 2009.
DISCUSSION
In this study, a variety of MRSA pulsotypes with few subtypes were isolated from HIV patients and HCPs. We observed no correlation between pulsotype and reduced susceptibility to antimicrobials. We found one hVISA isolate that also exhibited intermediate resistance to teicoplanin. The vanA gene responsible for complete glycopeptide resistance in S. aureus was not detected in any samples (data not shown). Teicoplanin resistance after vancomycin use has been reported (18) ; however, none of the patients in our study were treated with vancomycin or teicoplanin.
The mechanisms underlying daptomycin resistance are not well understood (19) (20) , but it is known that decreased susceptibility to daptomycin and vancomycin can co-occur both in vivo (20) and in vitro (21) after selection with either antimicrobial (21) . Although there is evidence for cross-resistance (21) , in this study, the hDRSA isolate remained susceptible to vancomycin. Since none of the patients had been treated with daptomycin, the basis for resistance is unclear, but is currently under study. Heterogeneous type resistance to daptomycin has been previously observed, and is in part attributed to dltA overexpression. The detection of teicoplanin-intermediate S. aureus, hVISA, and hDRSA is of great concern since these represent last-line antimicrobials for treating MRSA infection.
ST105 and ST148 are SLVs of ST5 and account for the majority of isolates typed in this study. ST30 is a prototype of CC30 and is associated with community-acquired infection. The isolate ST30-SCCmecIV was positive for PVL, which is consistent with MRSA strains found in the community (22) .
Although many subtypes isolated from patients can be considered as closely related according to Tenover's criteria (12) , only four pairs of patient strains yielded indistinguishable band patterns by PFGE. Interestingly, the isolate from P3 and the fi rst two isolates from P1 clustered with MRSA from different patients isolated 2 years prior-i.e., a clone related to ST5-SCCmecII that was circulating among patients in 2009. There was no evidence that these clones spread to the HIV patients studied in 2011. This clone is common in hospitals around the world, and has replaced BEC as the predominant MRSA clone in Brazil (23) .
Although it would be prudent, there is currently no rule in Brazil requiring removal from the work environment of a MRSA-positive HCP. British guidelines (24) (25) for the control of MRSA in healthcare facilities include screening of staff for this bacterium. HCPs with colonized or infected hand lesions are required to be off work while receiving clearance therapy since they are a source of dissemination to non-colonized patients (24) (25) . Moreover, HCPs work in different wards of a hospital, which increases opportunities for dissemination. Security and hygienic practices should also be verifi ed more frequently, since HCPs can be colonized on different dates even after undergoing decolonization, as we observed here.
In conclusion, HCPs were found to be colonized by ST105-SCCmecII in 2011 and 2012 and this strain had infected other patients in 2009. Although the same pulsotype was detected, we cannot conclude that these HCPs were in direct contact with patients and that dissemination occurred. Finally, there was no broad dissemination of a specifi c MRSA clone among HIV patients up to the 7 th day of hospitalization.
